Vote outcome on Proposal No. 4 will determine whether equity grant capacity auto-replenishes. If approved, expect continued equity compensation without further shareholder votes; if rejected, the company may need to seek authorization via another proxy statement or use cash compensation instead.
Price Chart
Executive Summary
OptimizeRx filed definitive additional proxy materials urging shareholders to vote FOR Proposal No. 4, which would amend the 2021 Equity Plan to include an evergreen provision allowing annual automatic increases of up to 5% of outstanding shares through 2031. The board argues this ensures sufficient equity for compensation without needing repeated shareholder votes, with safeguards including board discretion to reduce increases and a five-year plan expiration.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for June 9, 2026.
- Proposal No. 4 seeks adoption of an evergreen provision for the 2021 Equity Plan.
- Provision allows automatic annual increase of 5% of outstanding shares on each January 1 from 2027 to 2031.
- Board has discretion to reduce or eliminate any annual increase.
- Current share reserve plus 1,000,000 additional shares from Proposal No. 3 expected to last only one year.
- Evergreen provision designed to avoid future proxy solicitations solely to increase share pool.
- D.F. King & Co. retained as proxy solicitor for estimated fee of $20,000.
Financial Impact
Potential annual dilution of up to 5% of outstanding shares through 2031, though similar to historical authorization levels.
Risk Factors
- If approved, ongoing dilution of up to 5% annually could pressure EPS growth.
- If rejected, equity compensation constraints may impact retention and require higher cash expenses.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-063148 |
| Document: 0001213900-26-063148-index-headers.html | 0001213900-26-063148 |
| Document: 0001213900-26-063148-index.html | 0001213900-26-063148 |
| Document: 0001213900-26-063148.txt | 0001213900-26-063148 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Press Release | $9.15 | awaiting T+20 | — | $9.18 (+0.33%) |
Oct 21, 2026 5d ago | SC 13G/A | $9.37 | awaiting T+20 | — | $9.18 (−2.03%) |
Sep 22, 2026 4w ago | Institutional Cluster | $7.62 $8.93 | ▲ +17.19% | ▲ +17.75% | $9.18 (+20.47%) |
Aug 12, 2026 10w ago | Press Release | $8.78 $7.29 | ▼ −16.97% | ▼ −15.22% | $9.18 (+4.56%) |
Jun 12, 2026 19w ago | 8-K | $5.32 $6.55 | ▲ +23.12% | ▲ +23.87% | $9.18 (+72.56%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.28 $6.28 | ▲ +18.94% | ▲ +17.05% | $9.18 (+73.86%) |
Jun 5, 2026 20w ago | 8-K | $5.05 $6.35 | ▲ +25.74% | ▲ +24.11% | $9.18 (+81.78%) |
Jun 1, 2026 21w ago | DEFA14A | $5.38 $5.72 | ▲ +6.32% | ▲ +7.62% | $9.18 (+70.63%) |
May 21, 2026 22w ago | Press Release | $4.94 $4.70 | ▼ −4.86% | ▼ −5.19% | $9.18 (+85.83%) |
May 12, 2026 23w ago | Press Release | $4.92 $5.28 | ▲ +7.32% | ▲ +7.93% | $9.18 (+86.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers